Trials

A phase II non comparative study with paclitaxel and carboplatin in combination with vorinostat in patients with advanced recurrent epithelia ovarian carcinoma

Cancer type: Ovarian cancer

Phase: II

Principal Investigator: Heerstedt Jørn

Country: DK

Keywords: Denmark, Herlev, Platinum-sensitive ovarian cancer

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT00772798?term=NCT+00772798&rank=1